System Labs review

Choose a treatment question before choosing a catalog

System Labs is a peptide-focused telehealth service, not an established route to living longer. Its catalog includes NAD injection and nasal spray, glutathione, MIC with B12, and injectable and oral compounded sermorelin. It describes clinician review, pharmacy preparation and continuing support. ^[1] I would consider it only after an exact treatment question has been established. Browsing a catalog organized around recovery and longevity is a weak starting point for deciding whether a prescription is needed.

The distinction is practical. A reader asking about persistent fatigue, poor sleep or reduced physical function needs to understand the concern before choosing a product advertised for the same words. A service can provide convenient access without having demonstrated that its collection of treatments solves those problems or extends healthy life. My default recommendation is to keep the clinical question narrow, define the outcome that matters and require evidence for the proposed preparation.

For the difference between an attractive measurement and a demonstrated outcome, read what a biological-age result actually establishes.

The price needs a complete order summary

The NAD page labels a quarterly supply of 1,000 milligrams while advertising $76 for the first month beside a crossed $126 figure. ^[2] I would not turn those adjacent labels into a confirmed quarterly invoice or ongoing monthly bill. A buyer needs the actual total, what is supplied, the renewal interval and the price after the introductory period. Without those pieces, a comparison with a one-month alternative appears more precise than it really is.

The same discipline matters for sermorelin. Its product page shows a $99 monthly headline, while other presentations on the site show different introductory and comparison figures. ^{[1] [3]} I would request one written quote tied to the selected route and supply before using any of them as a budget. That is a reason to withhold a fixed cost field, not a reason to invent a price or accuse the service of concealing every term.

Formulation differences deserve their own answer

System treats injection and oral sermorelin as separate products and similarly distinguishes NAD injection from a nasal formulation. ^[1] Those are not cosmetic choices. I would ask the clinician to explain the evidence for the exact route, dose and desired outcome rather than carrying a claim about a molecule across every format in the store. A mechanism described at a cellular level is not a demonstration of a meaningful improvement in a consumer’s life.

This is particularly important when the goal is sleep, strength or recovery. Define a change that would actually matter: a persistent symptom assessed appropriately, a physical task becoming easier or a measurable treatment target chosen for a reason. Another favorable score can feel reassuring while leaving the original problem unanswered. A product should earn its place through the proposed clinical plan, not through the number of processes in which its ingredient participates.

For an alternative evidence question when function is the goal, consider strength-training evidence in older adults.

Support is valuable, but the outcome claim still needs evidence

The site describes a health intake followed by licensed-clinician review and shipping from U.S. pharmacies, and its disclosure says the peptide therapies offered have not been approved by the FDA. ^[1] I would judge those service features separately from the promised benefit. A clinician’s involvement and a pharmacy’s preparation responsibilities matter, but neither converts a seller’s healthy-aging language into proof of prolonged life or an established treatment for nonspecific symptoms.

If the reason for shopping is declining strength, compare the proposal with an appropriate assessment and an exercise plan. If the concern is sleep, distinguish a tracking problem from a problem requiring diagnosis. I would choose System only when the exact intervention, complete charge and review process are clear enough to evaluate on their own. For general prevention, I would put that money toward an identified need before buying an open-ended program justified mainly by the word longevity.

For the distinction between a sleep trend and a diagnosis, read when sleep needs clinical assessment.

Look for an assessment rather than an upsell

The most useful next step for unexplained symptoms may be an assessment that does not end with a purchase. I would want the clinical conversation to make that possibility real, including a clear explanation when a proposed intervention is unlikely to answer the concern. Compare the opportunity cost as well: money committed to a continuing injection program cannot simultaneously pay for a needed appointment, practical training support or a more established intervention. Those alternatives should not be dismissed because they lack a compelling molecular story. A discerning purchase decision can conclude that the product is clearly described and still not worth buying for the goal at hand.

Understanding the cost

NAD page advertises $76 first month next to $126 and a quarterly 1000 mg supply. Sermorelin price presentations vary. Exact prepaid total, selected formulation, ongoing rate and renewal require a written quote; no single reliable program price assigned.